Percutaneous coronary interventions with an endothelial progenitor cell capture stent (EPC) for high risk patients with no option for drug eluting stents: Long term clinical outcomes of a single centre registry

EuroIntervention

Volumn 6, Issue 7, 2011, Pages 826-830

  Scacciatella, Paolo ^a   Meliga, Emanuele ^b   D'Amico, Maurizio ^a   Amato, Gianluca ^a   Pennone, Mauro ^a   Conrotto, Federico ^a   Marra, Sebastiano ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b MAURIZIANO HOSPITAL   (Italy)

Author keywords

Dual antiplatelet therapy; Endothelial progenitor cells; Percutaneous coronary interventions

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR; HEPARIN; HIRULOG; INDOBUFEN; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DISEASE REGISTRY; DRUG DOSE TITRATION; DRUG ELUTING STENT; ENDOTHELIAL PROGENITOR CELL CAPTURE STENT; FEMALE; HEART DEATH; HIGH RISK PATIENT; HUMAN; LOADING DRUG DOSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; SAFETY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; STENT THROMBOSIS; UNSTABLE ANGINA PECTORIS;

AGED; BIOENGINEERING; COATED MATERIALS, BIOCOMPATIBLE; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY VESSELS; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; RISK FACTORS; STEM CELLS; STENTS;

EID: 79954453379     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I7A142     Document Type: Article

References (23)

1. Mintz GS, Hong MK, Raizner AE, Lee CW, Kim JJ, Escolar E, Fearnot NE, Park SW, Park SJ, Weissman NJ. Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents. Am J Cardiol. 2005;95:107-9. (Pubitemid 40051122)
2. Aoki J, Abizaid AC, Serruys PW, Ong AT, Boersma E, Sousa JE, Bruining N. Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients. J Am Coll Cardiol. 2005;46:1670-6. (Pubitemid 41531621)
3. Imanishi T, Kobayashi K, Kuki S, Takahashi C, Akasaka T. Sirolimus accelerates senescence of endothelial progenitor cells through telomerase inactivation. Atherosclerosis 2006;189:288-296. (Pubitemid 44634491)
4. Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, Ligthart JM, van Essen D, de Feyter PJ, Serruys PW. Indication of long term endothelial dysfunction after sirolimus eluting stent implantation. Eur Heart J 2006;27:166-170. (Pubitemid 43069032)
5. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202. (Pubitemid 43929240)
6. Aoki J, Serruys PW, van Beusekom K, Ong AT, McFadden P. Endothelial progenitor cell capturewith stents covered by antibody against CD34; the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth - First in man) Registry. J Am Coll Cardiol 2005;45:1574-79. (Pubitemid 40704488)
7. Duckers HJ, Soullié T, den Heijer P, Rensing B, de Winter R, Rau M, Mudra H, Silber S, Benit E, Verheye S, Wijns W, Serruys PW. Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow up: final results of the HEALING II trial using an endothelial progenitor cell capturing stent (Genous R stent). EuroIntervention 2007;3:350-358.
8. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51. (Pubitemid 46685903)
9. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB 3rd, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006;47:e1-121.
10. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007;369:667-78. (Pubitemid 46281313)
11. Azzarelli S, Amico F, Galassi AR, Giacoppo M, Argentino V, Fiscella A. Two-year clinical follow up of coronary drug-eluting stent in patients at high risk for coronary restenosis. J Invasive Cardiol. 2008;20:62-6. (Pubitemid 351271443)
12. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC. "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2008;51:607-14.
13. Macaya C, Garcia-Garcia HM, Colombo A, Morice MC, Legrand V, Kuck KH, Sheiban I, Suttorp MJ, Carrie D, Vrolix M, Wittebols K, Stoll HP, Donohoe D, Bressers M, Serruys PW. One-year results of coronary revascularization in diabetic patients with coronary artery disease. Sirolimus stent vs. coronary artery bypass surgery and bare metal stent: insight from ARTS-II and ARTS-I. EuroIntervention. 2006;2:69-76.
14. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998-1008;
15. Maisel WH. Unanswered questions - drug-eluting stents and the risk of late thrombosis. N Engl J Med. 2007;356:981-4. (Pubitemid 46376797)
16. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30. (Pubitemid 40617065)
17. Choi CU, Rha SW, Jin Z, Chen KY, Minami Y, Kim JH, Na JO, Suh SY, Kim JW, Kim EJ, Park CG, Seo HS, Oh DJ.The optimal timing for non-cardiac surgery after percutaneous coronary intervention with drug-eluting stents. Int J Cardiol. 2008;139:313-316.
18. Schouten O, van Domburg RT, Bax JJ, de Jaegere PJ, Dunkelgrun M, Feringa HH, Hoeks SE, Poldermans D. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007;49:122-124. (Pubitemid 46026891)
19. Reddy PR, Vaitkus PT. Risks of noncardiac surgery after coronary stenting. Am J Cardiol 2005;95:755-7. (Pubitemid 40332656)
20. Kutryk MJ, Kuliszewski MA. In vivo endothelial progenitor cellseeding for the accelerated endothelialization of endovascular devices. Am J Cardiol 2003;92:94L.
21. Roy P, Bonello L, Torguson R, de Labriolle A, Lemesle G, Slottow TL, Steinberg DH, Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R. Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation. Am J Cardiol. 2008;102:1614-7.
22. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, Kim SW, Bui A, Gevorkian N, Xue Z, Smith K, Fournadjieva J, Suddath WO, Satler LF, Pichard AD, Kent KM, Waksman R. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006;113:1108-13.
23. Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006;113:2803-09. (Pubitemid 44305292)